| Source | ABC Local |
|---|---|
| Original Load Date | Sept. 21, 2026, 9 p.m. |
| Last Updated | Sept. 21, 2026, 9 p.m. |
| Original URL | https://abc7chicago.com/story/wegovy-mounjaro-ozempic-vision-loss-what-users-should-know-glp-1-side-effects-potential-risk-naion/19856367/ |
Article Preview
CHICAGO -- Dozens of Americans have filed personal injury lawsuits against the
makers of popular GLP-1 drugs, like Ozempic, Wegovy and Mounjaro, claiming they
were not properly warned of the risk of a rare type of sudden vision loss,
called nonarteritic anterior ischemic optic neuropathy, or NAION,...